Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cormac Cosgrove

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Frontiers in Immunology|December 18, 2020
Antigen Specificity Enhances Disease Control by Tregs in VitiligoZhussipbek Mukhatayev, Emilia R Dellacecca, Cormac Cosgrove, et al.
Cancer Research|October 28, 2025
ABBV-303 is a Natural Killer Cell Engager Specific for c-Met-Expressing TumorsJennifer D Stone, Kamonwan Fish, Devika Ashok, et al.
Molecular Cancer Therapeutics|June 9, 2023
ABBV-184: A Novel Survivin-specific TCR/CD3 Bispecific T-cell Engager is Active against Both Solid Tumor and Hematologic MalignanciesAdam S Chervin, Jennifer D Stone, Iwona Konieczna, et al.
Plos Pathogens|October 21, 2015
CD39 Expression Identifies Terminally Exhausted CD8+ T CellsPrakash K Gupta, Jernej Godec, David Wolski, et al.
Leukemia & Lymphoma|June 18, 2025
Combinability of epcoritamab CD20-targeting T-cell engager and CD20 antibody-targeted therapies in B-cell non-Hodgkin lymphomaDurga B Dandamudi, Iwona M Konieczna, Kelly M Calabrese, et al.
Blood|December 21, 2012
Early and nonreversible decrease of CD161++ /MAIT cells in HIV infectionCormac Cosgrove, James E Ussher, Andri Rauch, et al.
Cell|June 18, 2019
Fc Glycan-Mediated Regulation of Placental Antibody TransferMadeleine F Jennewein, Ilona Goldfarb, Sepideh Dolatshahi, et al.
Blood|May 3, 2024
ABBV-319: a CD19-targeting glucocorticoid receptor modulator antibody-drug conjugate therapy for B-cell malignanciesChewei Anderson Chang, Ethan Emberley, Aloma L D'Souza, et al.
Nature Genetics|July 5, 2016
Genome-wide association of multiple complex traits in outbred mice by ultra-low-coverage sequencingJérôme Nicod, Robert W Davies, Na Cai, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Frontiers in Immunology|December 18, 2020
Antigen Specificity Enhances Disease Control by Tregs in VitiligoZhussipbek Mukhatayev, Emilia R Dellacecca, Cormac Cosgrove, et al.
Cancer Research|October 28, 2025
ABBV-303 is a Natural Killer Cell Engager Specific for c-Met-Expressing TumorsJennifer D Stone, Kamonwan Fish, Devika Ashok, et al.
Molecular Cancer Therapeutics|June 9, 2023
ABBV-184: A Novel Survivin-specific TCR/CD3 Bispecific T-cell Engager is Active against Both Solid Tumor and Hematologic MalignanciesAdam S Chervin, Jennifer D Stone, Iwona Konieczna, et al.
Plos Pathogens|October 21, 2015
CD39 Expression Identifies Terminally Exhausted CD8+ T CellsPrakash K Gupta, Jernej Godec, David Wolski, et al.
Leukemia & Lymphoma|June 18, 2025
Combinability of epcoritamab CD20-targeting T-cell engager and CD20 antibody-targeted therapies in B-cell non-Hodgkin lymphomaDurga B Dandamudi, Iwona M Konieczna, Kelly M Calabrese, et al.
Blood|December 21, 2012
Early and nonreversible decrease of CD161++ /MAIT cells in HIV infectionCormac Cosgrove, James E Ussher, Andri Rauch, et al.
Cell|June 18, 2019
Fc Glycan-Mediated Regulation of Placental Antibody TransferMadeleine F Jennewein, Ilona Goldfarb, Sepideh Dolatshahi, et al.
Blood|May 3, 2024
ABBV-319: a CD19-targeting glucocorticoid receptor modulator antibody-drug conjugate therapy for B-cell malignanciesChewei Anderson Chang, Ethan Emberley, Aloma L D'Souza, et al.
Nature Genetics|July 5, 2016
Genome-wide association of multiple complex traits in outbred mice by ultra-low-coverage sequencingJérôme Nicod, Robert W Davies, Na Cai, et al.
Pageof 3